Omar E. Wever-Pinzon, M.D.
NPI 1205926250ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· Miami, FL
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (M.D.) with University of Miami, practicing in Miami, Florida. Their prescriptions cost Medicare Part D more than their services did: $360,179 for 410 claims, against $36,648 paid for services in 2024. Abbott Laboratories was the largest of 4 companies reporting payments in 2025, $796.40 in all, mostly food and beverage. Lists Jackson Health System as a hospital affiliation.
Overview
| NPI | 1205926250 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Oct 13, 2006 |
| Last updated in NPPES | Oct 31, 2025 |
| Certified by provider | Oct 31, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | ME95870 | FL |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | ME95870 | FL |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (FL); Practitioner - Cardiovascular Disease (Cardiology) (UT) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 161 |
|---|---|
| Services billed | 471 across 26 procedure codes |
| Paid by Medicare | $36,648 |
Part D prescriptions in 2024
| Prescriptions (claims) | 410 · 884 30-day fills |
|---|---|
| Patients | 106 |
| Total drug cost | $360,179 |
| Generic share | 79% of claims |
Education and affiliations
| Graduation year | 1999 |
|---|---|
| Medicare specialty | Advanced Heart Failure And Transplant Cardiology |
| Secondary specialties | Cardiovascular Disease (Cardiology) |
| Telehealth | Offers telehealth |
Medical group
- University of MiamiMiami, FL · 2,377 clinicians
Hospital affiliation
- Jackson Health SystemMiami, FL
Industry payments (Open Payments)
- 2025$796.40 · 13 payments from 4 companies
- 2024$344.37 · 4 payments from 4 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Abbott Laboratories | $734.63 | 10 |
| Alnylam Pharmaceuticals Inc. | $22.97 | 1 |
| Pfizer Inc. | $22.80 | 1 |
| Astrazeneca Pharmaceuticals LP | $16.00 | 1 |
What the 2025 payments were for
- Food and Beverage$758.33 · 11 payments
- Travel and Lodging$38.07 · 2 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Miami
- 1831799055
- 1093005514
- 1043301997
- 1598007346
- 1972998961
- 1578574638
- 1124280789
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Florida →